Faith-based communities, places of worship, weddings, and funerals must continue to comply with the requirements set forth on the Centers for Disease Control (CDC) guidance and the Executive Orders from their Governors, State and local Health Departments. As churches are reconvening for public worship, some people in high-risk demographics should be encouraged to not physically attend regular worship services. The […]

U.S. hits a tragic milestone More than 500,000 people in the U.S. have now died from COVID-19. President Biden honored the victims in a memorial outside the White House: “The people we lost were extraordinary. They spanned generations.” “We often hear people described as ordinary Americans. There’s no such thing, there’s nothing ordinary about them,” Mr. Biden said during a […]

Key Points The CDC has asked states to ready facilities to distribute a coronavirus vaccine by Nov. 1. Dr. Anthony Fauci said at a health conference that it’s more likely a vaccine will be ready by “the end of the year.” Drug companies Moderna and Pfizer are racing to complete patient enrollment for their late-stage vaccine trials by the end […]

Letter from CDC head pushes for facilities to be fully operational two days before US election The Trump administration has urged US states to get ready to distribute a potential Covid-19 vaccine by November 1, in the latest sign of the accelerating race to deliver a vaccine by year’s end. “CDC urgently requests your assistance in expediting applications for these […]

We’re covering Russian plans for a nationwide coronavirus vaccination campaign, Britain’s dilemma if President Trump loses in November and a far-right extremist group in Germany. Russia plans mass vaccination after shortened trials Russia is planning a nationwide vaccination campaign in October with a coronavirus vaccine that has yet to complete clinical trials. The announcement has raised international concerns that the […]

In it, packed with dry ice, were several tiny vials. Each one held a few drops of “seed stock,” a starter kit for the production of a potential vaccine for the novel coronavirus.
The company’s job was to turn a few droplets into an amount large enough for 13,000 people — a sufficient quantity to perform ­large-scale trials unfolding on several continents.
“We could really feel the pressure,” said Francesco Calvaruso, the production manager of Advent, which needed two months to grow, filter and purify a trial vaccine known as AZD1222.